Keiichi Tamai Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2016	ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways.
1/2011	The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiichi Tamai Research Topics

Disease

36	Neoplasms (Cancer) 05/2024 - 01/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 06/2013
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 01/2019
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2013
4	Hypopharyngeal Neoplasms 10/2022 - 01/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2016
3	Cholangiocarcinoma 01/2021 - 06/2014
2	Squamous Cell Carcinoma of Head and Neck 05/2024 - 01/2019
2	Carcinogenesis 01/2023 - 02/2015
2	Lung Neoplasms (Lung Cancer) 03/2019 - 07/2018
2	Adenocarcinoma 01/2019 - 03/2018
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2017 - 05/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2011
2	Fibrosis (Cirrhosis) 01/2011 - 12/2009
2	Liver Diseases (Liver Disease) 08/2010 - 02/2006
2	Infections 07/2010 - 06/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023
1	Adenocarcinoma of Lung 11/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Neuroblastoma 10/2022
1	Esophageal Neoplasms (Esophageal Cancer) 08/2022
1	Inflammation (Inflammations) 05/2022
1	Weight Loss (Weight Reduction) 05/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Carcinoma (Carcinomatosis) 04/2020
1	Melanoma (Melanoma, Malignant) 10/2019
1	Colitis 04/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Lymphoma (Lymphomas) 03/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017

Drug/Important Bio-Agent (IBA)

9	Adapalene (Differin)FDA LinkGeneric 05/2024 - 01/2013
9	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2006
5	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 05/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2010
3	Long Noncoding RNAIBA 01/2018 - 01/2013
3	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2009
2	Messenger RNA (mRNA)IBA 05/2024 - 01/2011
2	Untranslated RNA (Noncoding RNA)IBA 05/2024 - 06/2013
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2023 - 10/2019
2	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2015
2	Protein Isoforms (Isoforms)IBA 01/2023 - 05/2017
2	Monoclonal AntibodiesIBA 08/2022 - 10/2019
2	Glycoproteins (Glycoprotein)IBA 08/2022 - 04/2020
2	CytokinesIBA 05/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 01/2011
2	alectinibIBA 01/2021 - 03/2019
2	Carrier Proteins (Binding Protein)IBA 12/2020 - 01/2017
2	PeriostinIBA 07/2018 - 04/2018
2	Pyruvate KinaseIBA 03/2018 - 05/2017
2	Amino Acids FDA Link 01/2011 - 12/2009
2	Alanine Transaminase (SGPT)IBA 08/2010 - 07/2010
1	Annexin A2 (Annexin II)IBA 03/2024
1	Cell-Free Nucleic AcidsIBA 11/2023
1	osimertinibIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 05/2023
1	B7-H1 AntigenIBA 05/2023
1	Environmental CarcinogensIBA 01/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Cholinergic ReceptorsIBA 01/2023
1	NF-kappa B (NF-kB)IBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	Tamoxifen FDA LinkGeneric 05/2022
1	matrigelIBA 12/2021
1	CollagenIBA 12/2021
1	involucrinIBA 12/2021
1	Circulating Tumor DNAIBA 11/2021
1	Formaldehyde (Formol)FDA Link 03/2021
1	ParaffinIBA 03/2021
1	nanolucIBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	entrectinibIBA 01/2021
1	bis(4-methylumbelliferyl)pyrophosphateIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	gilteritinibIBA 01/2021
1	lorlatinibIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2020
1	Small Interfering RNA (siRNA)IBA 04/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 04/2020
1	AntibodiesIBA 02/2020
1	IntegrinsIBA 04/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018
1	Pyruvic Acid (Pyruvate)IBA 03/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2017
1	Carbonic Anhydrase IXIBA 03/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Semaphorins (Semaphorin)IBA 09/2016

Therapy/Procedure

4	Therapeutics 05/2023 - 12/2020
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2021
1	Euthanasia (Mercy Killing) 05/2022
1	Heterologous Transplantation (Xenotransplantation) 05/2016